Navigation Links
Cancer drugs may help stop major parasite
Date:7/16/2010

A parasite estimated to afflict as many as 12 million people worldwide relies on a family of genes that should make it vulnerable to compounds developed to treat cancer and other disorders, researchers at Washington University School of Medicine in St. Louis have found.

Scientists searched the genome of the parasite Leishmania to determine that it has three kinds of TOR kinases, proteins that are linked to cell growth and cancer and have been longstanding targets for drug development. When they removed the proteins individually, they found that all three were critical either to the parasite's ability to survive or its ability to cause infections.

"If we can hit any of these proteins with a drug that will inhibit them, we should be able to strike a significant blow against Leishmania," says senior author Stephen Beverley, PhD, the Marvin A. Brennecke Professor and head of Molecular Microbiology. "Given the numerous inhibitors already available, I think there's a pretty good chance that we'll be able to identify a compound that specifically inhibits one of Leishmania's TOR kinases."

The finding appears online in The Proceedings of the National Academy of Sciences.

Infection with the Leishmania parasite, or leishmaniasis, is mainly spread by sand fly bites and is a major public health problem in Asia, Africa, the Middle East and other parts of the developing world. Symptoms include large skin lesions, fever, swelling of the spleen and liver, and, in more serious forms of the disease, disfigurement. The most severe form of leishmaniasis, a condition sometimes called black fever, is fatal if left untreated and is estimated to kill more humans than any other parasite except Plasmodium falciparum, the malaria parasite.

Mammals have only one TOR kinase protein, and drug developers have targeted it to block immune system rejection of transplanted organs, to treat certain forms of cancer an
'/>"/>

Contact: Michael C. Purdy
purdym@wustl.edu
314-286-0122
Washington University School of Medicine
Source:Eurekalert  

Page: 1 2

Related biology news :

1. WSU researchers find way to make cancer cells more mortal
2. New arsenic nanoparticle blocks aggressive breast cancer
3. Mechanism for link between high fat diet and risk of prostate cancer and disorders unveiled
4. Divide and conquer: Genes decide who wins in the bodys battle against cancer
5. Mahjong gene is key player when cancer, normal cells compete
6. CWRU dental researchers discover human beta defensins-3 ignite in oral cancer growth
7. The Samuel Waxman Cancer Research Foundation awards $1.54 million in research grants for 2010-2011
8. A*STAR scientists score hat-trick against cancer
9. Innovation and current status of prostate cancer gene therapy featured in Human Gene Therapy
10. Damon Runyon Cancer Research Foundation awards prestigious fellowships to 18 top young scientists
11. DNA discovery opens new door to develop tools, therapies for hereditary cancers
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Cancer drugs may help stop major parasite
(Date:8/19/2014)... To improve students, chances of completing introductory biology ... Houston (UH) implemented a comprehensive student success program, ... failure. , Through a grant from the ... of Biology and Biochemistry embarked on a pilot ... for non-majors and "Introductory Biology" for science majors. ...
(Date:8/19/2014)... available in German . ... energy sources. If a large amount of electricity is to ... energy will have to be stored during productive periods so ... capacities are far from adequate for the purpose. Science and ... focus lies on battery systems that used to be too ...
(Date:8/19/2014)... a lemur. It,s not an African Bush Baby or even ... and downright "cool" primate from Southeast Asia. , "It,s really ... Rafe Brown, curator-in-charge at the University of Kansas, Biodiversity Institute. ... furry body; a long tail with a furry tuft at ... look a bit like the disks on the digits of ...
Breaking Biology News(10 mins):University of Houson program earns kudos for improving grades, retaining students 2University of Houson program earns kudos for improving grades, retaining students 3Asian inventions dominate energy storage systems 2Asian inventions dominate energy storage systems 3Philippine tarsier gets boost from Kansas research, and genetic proof of a new variety 2Philippine tarsier gets boost from Kansas research, and genetic proof of a new variety 3
... , MADISON - The continued growth of cropland ... agricultural landscapes in the Midwest. A Great Lakes ... simplification is associated with increased crop pest abundance ... by perennial bioenergy crops. While the relationship ...
... LEXINGTON, Ky. − A team of researchers led by ... is making a connection from prehistoric times to the ... create a replacement for oil and coal shale deposits. ... the earth,s energy supply. Tom Niehaus, completing his ...
... Health care laws to protect patients, privacy make ... and test the safety and usability of medical products ... a result, usability errors and hazards may be overlooked, ... issue of Ergonomics in Design, human factors/ergonomics ...
Cached Biology News:Landscape change leads to increased insecticide use in the Midwest 2University of Kentucky-led research could be path to new energy sources 2
(Date:8/19/2014)... XenoTech announces an exclusive partnership with ... from bioactive small molecules. Based on an ... convenient and timely assessment of critical metabolite and ... of Commercial Operations, Christian Darabant, “the value of ... be measured directly by comparison with the approximate ...
(Date:8/19/2014)... CSSi, the leader in patient recruitment solutions ... of the company,s Medical and Clinical Advisory Board ("MCAB") ... William E. Gannon, Jr. to the MCAB. ... The MCAB, with Dr. Gannon,s leadership, will help ... set strategic goals for the advancement and development of ...
(Date:8/19/2014)... ROCKVILLE, Md. , Aug. 19, 2014 /PRNewswire/ ... a biotechnology company developing novel anti-infective biologic and ... infections and diseases, announced today that its novel ... highlighted at the 54 th Interscience Conference ... in Washington D.C. ...
(Date:8/19/2014)... Sales Horizons, a leader in sales ... sales skills training course to help companies develop ... staff spend the majority of their time on client ... or physician practice – providing support and education to ... Sales Horizons believes clinical staff are and should be ...
Breaking Biology Technology:Beyond Metabolite Identification, Testable Quantities Now Offered by XenoTech 2Beyond Metabolite Identification, Testable Quantities Now Offered by XenoTech 3CSSi Appoints Dr. William E. Gannon, Jr. to Newly Formed Medical and Clinical Advisory Board 2CSSi Appoints Dr. William E. Gannon, Jr. to Newly Formed Medical and Clinical Advisory Board 3Synthetic Biologics Announces Late-Breaking Poster Presentation for C. difficile Program at 54th ICAAC 2Synthetic Biologics Announces Late-Breaking Poster Presentation for C. difficile Program at 54th ICAAC 3Synthetic Biologics Announces Late-Breaking Poster Presentation for C. difficile Program at 54th ICAAC 4Sales Horizons Launches a New Online Sales Training Course for MedTech Clinical Staff to Develop Their Sales Skills 2Sales Horizons Launches a New Online Sales Training Course for MedTech Clinical Staff to Develop Their Sales Skills 3
... and HONG KONG, Nov. 22, 2011 SuperNova Diagnostics®, Inc., ... health applications, announced that Neil J. Campbell, President and ... Jaffray Healthcare Conference on November 30, 2011 at 10:30 ... Madison Avenue, New York. The presentation will ...
... Ltd today announced that data from Phase 2 studies ... inhibitor pracinostat (SB939) demonstrate promising activity in patients with ... ASH Annual Meeting and Exposition in San Diego, Calif. ... has shown activity in alleviating MF-associated splenomegaly and constitutional ...
... The streaming of real-time information across your field of vision ... a prototype contact lens that could potentially provide the wearer ... today, 22 November, in IOP Publishing,s Journal of Micromechanics ... demonstrated its safety by testing it on live eyes. There ...
Cached Biology Technology:SuperNova Diagnostics® to Present at the 23rd Annual Piper Jaffray Healthcare Conference in New York City 2S*BIO's Novel JAK2 Inhibitor Pacritinib (SB1518) and Histone Deacetylase Inhibitor Pracinostat (SB939) Demonstrate Promising Activity in Phase 2 Studies for Patients with Myelofibrosis (MF) 2S*BIO's Novel JAK2 Inhibitor Pacritinib (SB1518) and Histone Deacetylase Inhibitor Pracinostat (SB939) Demonstrate Promising Activity in Phase 2 Studies for Patients with Myelofibrosis (MF) 3Terminator-style info-vision takes step towards reality 2
... Inhibitors have broad spectrum RNase inhibitory properties, ... the neutral type (1). The 50kDa protein ... to RNases in a 1:1 ratio. The ... Ribonuclease Inhibitor to RNase (e.g., RNase A) ...
...
Canine Aortic Smooth Muscle Cells (CnAOSMC) (>500,000 cells)...
... For nucleofection of optimized cell lines ... including the nucleofection parameters. Nucleofector Kits are ... Device., Different cell lines can be transfected ... viabilities are given in brackets in percent ...
Biology Products: